The Clinical Reasoning Gap: Why Most LLMs Fail at Longitudinal Health Data
Deep dive into how different LLMs analyze my 10 years of hormone and microbiome data
In the race to integrate artificial intelligence into clinical workflows, there is a dangerous assumption that “summarization” is the same as “reasoning.” Recent internal testing at Biocanic suggests otherwise.
We recently conducted a “Battle Royale” between the industry’s leading Large Language Models (LLMs) Claude 4.6 Opus, Gemini 2.5 Pro, and Grok 3, to see which could truly act as a clinical co-pilot for practitioners. The challenge was significant: interpret a dataset containing 2,464 rows of patient lab data, spanning nearly a decade of DUTCH and GI-MAP results. We gave them the GI Map and DUTCH clinical interpretive guides and a single prompt: “Can you interpret all my GI Map and Dutch test results?”
The results revealed a stark divide between models that simply “read” data and those that “understand” it.
The “Smoking Gun” of Clinical Logic
The definitive test of reasoning was a massive, 165x spike in testosterone levels found in the longitudinal data.
The Winner: Claude 4.6 Opus was the only model to correctly deduce that this spike was almost certainly exogenous Testosterone Replacement Therapy (TRT). This deduction reframed the entire clinical picture, allowing the model to correctly identify why HDL levels dipped and how the TRT was confounding kidney function markers like creatinine.
The Error: Gemini 2.5 Pro misread this same data as “adrenal stress” driven by gut inflammation. It went as far as recommending an endocrinologist consultation to rule out an “adrenal tumor”, a massive clinical “hallucination” when the simplest explanation (TRT) was visible in the history.
The Miss: Grok 3 provided a shallow analysis, suggesting “natural 5a-reductase inhibitors” for the spike. It failed to recognize that a value of 8,860 ng/mg is physically impossible through natural endogenous production alone
To understand why Claude 4.6 Opus emerged as the superior clinical co-pilot, we have to look beyond the prompt and into the architectural differences in how these models handle high-dimensional, longitudinal data.
While most LLMs are excellent at “pattern matching,” Opus demonstrated a unique capacity for synthetic reasoning, the ability to hold thousands of disparate data points in active “attention” and build a logical narrative between them.
Here is the technical breakdown of why Opus outperformed Gemini 2.5 Pro and Grok 3 in our clinical benchmark.
1. Claude 4.6 Opus: High-Fidelity Attention & Multi-Variable Synthesis
The primary reason Opus succeeded where others failed lies in its Attention Mechanism. When processing 2,464 rows of lab data, a model must decide which specific tokens (numbers) are “important” relative to others.
Long-Context Stability: Many models suffer from “middle-of-the-document” loss, where they ignore data buried in the center of a large file. Opus maintained high fidelity across the entire 10-year history. It didn’t just see the 165x testosterone spike; it “remembered” the baseline from five years prior.
Synthetic Reasoning: Opus excelled at “joining” different data schemas. It took the microbiome markers (GI-MAP), the hormonal metabolites (DUTCH), and the blood chemistry (CMP) and treated them as a single biological system. It realized that the drop in HDL wasn’t an isolated cardiovascular event, but a known side effect of the exogenous testosterone it had identified elsewhere in the set.
2. Gemini 2.5 Pro: The “Probabilistic” Trap
Gemini 2.5 Pro is a massive, highly capable model, but our testing suggests it relies more heavily on probabilistic pattern matching than first-principles logic.
Pattern Overdose: In the majority of medical literature, “high cortisol + gut issues” equals “adrenal stress.” Gemini defaulted to this common “textbook” association. Because the probability of “adrenal stress” is high in training data, the model “hallucinated” a path to that diagnosis, even though the raw data (the 165x spike) made that conclusion physically impossible.
Weighted Reasoning Failure: Gemini failed to “weigh” the significance of the 8,860 ng/mg figure correctly. It treated that number as just another data point rather than a “system-defining” outlier. In a clinical setting, this is the difference between a student who has memorized a textbook and a practitioner who understands physiology.
3. Grok 3: Breadth Over Depth
Grok 3 showed impressive speed and “personality,” but it struggled with high-dimensional logic.
Shallow Contextualization: Grok’s analysis was largely linear. It would comment on a GI-MAP marker, then a DUTCH marker, but it failed to build a “cross-talk” model between them.
Magnitude Sensitivity: Like Gemini, Grok lacked “magnitude sensitivity.” By suggesting natural 5a-reductase inhibitors for an 8,000+ ng/mg testosterone level, it revealed a lack of underlying “world model” regarding human biology. It treated the number as a “high value” but didn’t understand the scale of that height in a biological context.
The Technical Verdict: “System 2” Thinking
In cognitive psychology, “System 1” is fast, instinctive, and emotional (pattern matching), while “System 2” is slower, more deliberative, and logical.
Claude 4.6 Opus appears to have a more robust System 2 equivalent. When it encountered the 165x spike, its reasoning “stopped” to reconcile that outlier with the rest of the data. Instead of forcing the data into a pre-existing pattern (like Gemini’s adrenal stress theory), it updated its “internal model” of the patient to include TRT, and then re-evaluated every other marker through that new lens.
The “So What?”
For Biocanic Nexus, this technical distinction is the difference between an AI that provides a “summary” and an AI that provides a “discovery.”
For AI to truly enable providers in a meaningful way, the LLM must not only summarize the data, it needs to provide the same insights the practitioner would uncover, but in a faster way than combing through 10 years of data manually.
This comparison is only a snapshot in time and undoubtedly Gemini and Grok will also improve, but this highlights the importance of understanding the foundational LLM you are using.

For a deeper discussion on AI in personalized health, check out our Precision Protocol discussion here https://www.youtube.com/watch?v=_81Ri-Uh-NA